Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00485693 · ClinicalTrials.gov registry record · Phase 2
Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty
A Phase 2 study of Postoperative Pain, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 138
- Enrollment target
- 9
- Study locations
NCT00485693 is a Phase 2 study of Postoperative Pain that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 138 participants, below the 229-participant average among 63 other Postoperative Pain trials with a reported enrollment target (40% lower). The trial reports 9 study locations across 6 states.
The verdict
NCT00485693, a Phase 2 study of Postoperative Pain, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 138 participants
- Enrollment target
- 9
- Study locations
Study Summary
Dose-ranging study for prolonged postoperative analgesia in subjects undergoing total knee arthroplasty
Conditions Studied
Interventions
- DRUG Bupivacaine HCl
- DRUG SKY0402
Study Locations (9)
Other
- Urazova Nemocnice Brno - Brno
- Regional Hospital Kladno - Kladno
- The Hospital Trebic - Třebíč
California
- California Clinical Research, Inc. - Davis
- Accurate Clinical Trials, Inc. - Laguna Hills
Alabama
- West Alabama Research, Inc. - Birmingham
New York
- St. Luke's Roosevelt Hospital - New York
Ohio
- The Ohio State University Medical Center - Columbus
Texas
- Texas Tech University Health Science Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00485693
The ClinicalTrials.gov registry entry for NCT00485693 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 63 other Postoperative Pain trials with a reported enrollment target (40% lower). The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine HCl is the first listed.
NCT00485693 reports 9 study locations spanning 6 distinct geographic areas - top geographies include Other, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT00485693 about?
NCT00485693 is a clinical study titled "Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty". Dose-ranging study for prolonged postoperative analgesia in subjects undergoing total knee arthroplasty
What is the current status of trial NCT00485693?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 138 participants. The study started on 2007-06. Estimated completion is 2009-08.
What conditions does trial NCT00485693 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT00485693?
The interventions under investigation include: Bupivacaine HCl (DRUG), SKY0402 (DRUG).
Who is sponsoring clinical trial NCT00485693?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00485693 being conducted?
This trial has 9 study locations across Alabama, California, New York, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
-
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
RECRUITING · Phase 2
-
Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty
RECRUITING · Phase 2
-
Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy
COMPLETED · Phase 2
-
Phase 2 Bunionectomy HTX-011 Administration Study
COMPLETED · Phase 2
-
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.